--- title: Clorox (CLX) — intrinsic value and fair price canonical: https://sweetvaluelab.com/stocks/clx ticker: CLX as_of: 2026-10-17 sector: Consumer Defensive industry: Household & Personal Products --- # Clorox (CLX) Clorox (CLX) closed at $87.09 on Oct 16, 2026, undervalued by 39% vs its model value of $142.00 (from a five-year discounted cash flow). ## Key figures | Figure | Value | | --- | ---: | | Last close | $87.09 (Oct 16, 2026) | | Model value (from a five-year discounted cash flow) | $142.00 | | Price vs model | undervalued by 39% vs model | | Range of that model | $83.94 – $397.38 | | Market value | $10.5B | | P/E (fiscal 2025) | 13.4 | | Net margin (fiscal 2025) | 8.7% | | Free cash flow (fiscal 2025) | $761.0M | | Dividend yield (trailing twelve months) | 5.71% | | Beta | 0.57 | | Cost of capital (WACC) | 7.26% | | Business classification | Dividend Payer (Revenue declining (~-2% recent), Moderate margins (11% net margin), Strong dividend yield, Highly cyclical earnings, High leverage (D/E 7.8x), Strong FCF yield (7.2%)) | ## On the stock lists | List | Place | Figure | Page | | --- | ---: | ---: | --- | | Highest dividend yield | #16 | 5.71% | https://sweetvaluelab.com/lists/highest-dividend-yield | | Lowest P/E | #48 | 13.4× | https://sweetvaluelab.com/lists/lowest-pe | | Dividend growth streaks | #9 | 42 years | https://sweetvaluelab.com/lists/dividend-growth-streaks | ## Dividends | Figure | Value | | --- | ---: | | Trailing dividend yield | 5.71% | | Dividends per share, last 12 months | $4.97 | | Dividends / free cash flow (fiscal 2025) | 79.1% | | Raised | 42 years in a row | | Growth over 5 years | 2.1% a year | | Latest payment | $1.25, ex-date Aug 12, 2026, paid Aug 28, 2026 | | Year of payments | Dividends per share | | --- | ---: | | To Jul 27, 2021 | $4.49 | | To Jul 26, 2022 | $4.66 | | To Aug 8, 2023 | $4.74 | | To Aug 14, 2024 | $4.82 | | To Aug 13, 2025 | $4.90 | | Trailing twelve months (to Aug 12, 2026) | $4.97 | ## Valuation models Each model's value per share and the role the engine gave it for this business. The headline above is one model's value; every other model is listed with its own, and each has a page of its own under the valuation. Computed Oct 17, 2026. | Model | Role | Value per share | Low | High | | --- | --- | ---: | ---: | ---: | | DCF · Perpetuity growth · 5y | primary | $142.00 | $83.94 | $397.38 | | DCF · Perpetuity growth · 10y | cross check | $163.14 | $99.23 | $440.70 | | DCF · EBITDA exit · 5y | cross check | $158.40 | $108.02 | $217.83 | | DCF · EBITDA exit · 10y | cross check | $177.93 | $119.38 | $256.28 | | P/E · peers | cross check | $168.49 | $123.46 | $193.04 | | P/E · own history | cross check | $238.92 | $117.18 | $433.58 | | PEG | sanity check | $44.17 | $44.17 | $44.17 | | EV/EBITDA · peers | cross check | $152.39 | $128.18 | $203.87 | | EV/Revenue · peers | cross check | $147.56 | $68.51 | $215.65 | | Earnings power value | cross check | $66.52 | $51.93 | $88.72 | | Dividend discount | cross check | $97.77 | $65.87 | $167.59 | ## Insider activity (SEC Form 4) No open-market insider buys or sales filed in the past 90 days. | Date | Insider | Relationship | Transaction | Shares | Value | | --- | --- | --- | --- | ---: | ---: | | Oct 5, 2026 | Rendle Linda J | Chief Executive Officer | Grant / award | 29,352 | $2.4M | | Oct 5, 2026 | Rendle Linda J | Chief Executive Officer | Tax withholding | 11,989 | $964,035.5 | | Oct 5, 2026 | Rendle Linda J | Chief Executive Officer | Tax withholding | 692 | $55,643.7 | | Oct 5, 2026 | Peck Laurene E | VP - CAO & Corp Controller | Grant / award | 1,172 | $94,240.5 | | Oct 5, 2026 | Peck Laurene E | VP - CAO & Corp Controller | Tax withholding | 339 | $27,259 | ## Recent SEC filings | Filed | Form | What | Filing | | --- | --- | --- | --- | | Oct 7, 2026 | ARS | Annual report to shareholders | https://www.sec.gov/Archives/edgar/data/21076/000155278126000518/e26406_clx-ars.pdf | | Oct 7, 2026 | DEFA14A | Additional proxy materials | https://www.sec.gov/Archives/edgar/data/21076/000155278126000517/e26405_clx-defa14a.htm | | Oct 7, 2026 | DEF 14A | Proxy statement | https://www.sec.gov/Archives/edgar/data/21076/000155278126000516/e26316_clx-def14a.htm | | Aug 7, 2026 | 10-K | Annual report | https://www.sec.gov/Archives/edgar/data/21076/000002107626000034/clx-20260630.htm | | Aug 3, 2026 | 8-K | 2.02 Results of Operations (Earnings); 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/21076/000002107626000028/clx-20260803.htm | ## Superinvestors holding it (latest 13F) | Manager | Quarter | Shares | Value | | --- | --- | ---: | ---: | | Terry Smith | 2026-06-30 | 271,318 | $25.9M | | Yacktman | 2026-06-30 | 48,095 | $4.6M | | Jensen | 2026-06-30 | 47,805 | $4.6M | | Bridgewater | 2026-06-30 | 7,005 | $668,557 | 6 tracked managers in all. ## About The Clorox Company is a global manufacturer and marketer of both consumer and professional products, operating through four distinct segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness division offers a range of cleaning solutions, including laundry additives and home care items under brand names such as Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409. It also supplies professional cleaning and disinfecting products via the CloroxPro and Clorox Healthcare brands, alongside professional food service goods from Hidden Valley. Additionally, this segment provides vitamins, minerals, and supplements (VMS) within the United States, marketed under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light labels. Dedicated to the U.S. market, the Household segment features cat litter products from Fresh Step and Scoop Away,… --- Source: https://sweetvaluelab.com/stocks/clx (SweetValueLab, free, no account). Prices and statements from Financial Modeling Prep; filings from SEC EDGAR. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.